在染色体不稳定性方面取决于你的NEK2。 - Suppr

Suppr

超能文献

Up to your NEK2 in CIN.

作者信息

Seachrist Darcie D, Anstine Lindsey J, Keri Ruth A

出版信息

Oncotarget. 2021 Apr 13;12(8):723-725. doi: 10.18632/oncotarget.27918.

DOI:10.18632/oncotarget.27918

PMID:33889296

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8057269/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c7b/8057269/6c96405099b5/oncotarget-12-723-g001.jpg

相似文献

Up to your NEK2 in CIN.在染色体不稳定性方面取决于你的NEK2。

Oncotarget. 2021 Apr 13;12(8):723-725. doi: 10.18632/oncotarget.27918.

NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers.NEK2 主要通过激活外排药物泵诱导耐药性，与骨髓瘤和其他癌症的不良预后相关。

Cancer Cell. 2013 Jan 14;23(1):48-62. doi: 10.1016/j.ccr.2012.12.001.

Mitotic perturbations induced by Nek2 overexpression require interaction with TRF1 in breast cancer cells.Nek2过表达诱导的有丝分裂扰动需要与乳腺癌细胞中的TRF1相互作用。

Cell Cycle. 2013 Dec 1;12(23):3599-614. doi: 10.4161/cc.26589. Epub 2013 Sep 30.

Genetic polymorphisms in centrobin and Nek2 are associated with breast cancer susceptibility in a Chinese Han population.中心体结合蛋白和 Nek2 基因多态性与中国汉族人群乳腺癌易感性相关。

Breast Cancer Res Treat. 2012 Nov;136(1):241-51. doi: 10.1007/s10549-012-2244-9. Epub 2012 Sep 23.

Fundam Clin Pharmacol. 2022 Oct;36(5):766-776. doi: 10.1111/fcp.12777. Epub 2022 Apr 2.

The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer.中心体激酶Nek2在人类乳腺癌中表现出蛋白质表达水平升高。

Cancer Res. 2004 Oct 15;64(20):7370-6. doi: 10.1158/0008-5472.CAN-04-0960.

Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer.游离 DNA 测序的全基因组染色体不稳定性可预测转移性乳腺癌患者的生存情况。

Breast. 2020 Oct;53:111-118. doi: 10.1016/j.breast.2020.07.004. Epub 2020 Jul 25.

NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma.NEK2介导多发性骨髓瘤中醛脱氢酶1A1（ALDH1A1）依赖性耐药。

Oncotarget. 2014 Dec 15;5(23):11986-97. doi: 10.18632/oncotarget.2388.

Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells.突变型p53通过上调乳腺癌细胞中的Nek2驱动杂合性缺失。

Breast Cancer Res. 2020 Dec 2;22(1):133. doi: 10.1186/s13058-020-01370-y.

A screen for selective killing of cells with chromosomal instability induced by a spindle checkpoint defect.一种用于筛选由纺锤体检查点缺陷引起的染色体不稳定性的细胞的方法。

PLoS One. 2012;7(10):e47447. doi: 10.1371/journal.pone.0047447. Epub 2012 Oct 15.

本文引用的文献

Exploiting Chromosomal Instability of PTEN-Deficient Triple-Negative Breast Cancer Cell Lines for the Sensitization against PARP1 Inhibition in a Replication-Dependent Manner.利用PTEN缺陷型三阴性乳腺癌细胞系的染色体不稳定性以复制依赖的方式增强对PARP1抑制的敏感性。

Cancers (Basel). 2020 Sep 29;12(10):2809. doi: 10.3390/cancers12102809.

LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance.LIN9 和 NEK2 是有丝分裂保真度的核心调节因子，可作为治疗靶点以克服紫杉烷类耐药性。

Cancer Res. 2020 Apr 15;80(8):1693-1706. doi: 10.1158/0008-5472.CAN-19-3466. Epub 2020 Feb 13.

Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database.新辅助化疗与辅助化疗治疗三阴性乳腺癌的临床结局：来自国家癌症数据库的报告。

PLoS One. 2019 Sep 19;14(9):e0222358. doi: 10.1371/journal.pone.0222358. eCollection 2019.

NEK2 Is an Effective Target for Cancer Therapy With Potential to Induce Regression of Multiple Human Malignancies.NEK2是癌症治疗的有效靶点，具有诱导多种人类恶性肿瘤消退的潜力。

Anticancer Res. 2019 May;39(5):2251-2258. doi: 10.21873/anticanres.13341.

The impact of mitotic errors on cell proliferation and tumorigenesis.有丝分裂错误对细胞增殖和肿瘤发生的影响。

Genes Dev. 2018 May 1;32(9-10):620-638. doi: 10.1101/gad.314351.118.

Profound Tissue Specificity in Proliferation Control Underlies Cancer Drivers and Aneuploidy Patterns.深刻的组织特异性在增殖控制中是癌症驱动因素和非整倍体模式的基础。

Cell. 2018 Apr 5;173(2):499-514.e23. doi: 10.1016/j.cell.2018.02.037. Epub 2018 Mar 22.

BETi induction of mitotic catastrophe: towing the LIN9.溴结构域和末端外结构域抑制剂（BETi）诱导有丝分裂灾难：牵引LIN9。

Oncoscience. 2017 Oct 23;4(9-10):128-130. doi: 10.18632/oncoscience.372. eCollection 2017 Sep.

A systematic analysis of FDA-approved anticancer drugs.对美国食品药品监督管理局（FDA）批准的抗癌药物的系统分析。

BMC Syst Biol. 2017 Oct 3;11(Suppl 5):87. doi: 10.1186/s12918-017-0464-7.

Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors.与LIN9相关的三阴性乳腺癌中的有丝分裂易损性可被BET抑制剂靶向作用。

Cancer Res. 2017 Oct 1;77(19):5395-5408. doi: 10.1158/0008-5472.CAN-17-1571. Epub 2017 Aug 14.

Chromosomal Instability as a Driver of Tumor Heterogeneity and Evolution.染色体不稳定作为肿瘤异质性和进化的驱动因素

Cold Spring Harb Perspect Med. 2017 Jun 1;7(6):a029611. doi: 10.1101/cshperspect.a029611.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验